Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04476485
What this trial is testing

Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy

Who this might be right for
Breast Cancer
Shengjing Hospital 1,000
Not applicableEnded earlyNCT05560685
What this trial is testing

SMART-ER: Symptom Monitoring With Patient-reported Outcomes

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10
Large-scale testing (Phase 3)UnknownNCT01222052
What this trial is testing

6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients

Who this might be right for
Breast Cancer
Martin-Luther-Universität Halle-Wittenberg 4,150
Large-scale testing (Phase 3)Looking for participantsNCT07762885
What this trial is testing

Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery

Who this might be right for
Ductal Carcinoma In Situ, DCIS
Fudan University 636
Large-scale testing (Phase 3)UnknownNCT00003678
What this trial is testing

Tamoxifen in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
University Hospital Birmingham 20,000
Large-scale testing (Phase 3)UnknownNCT00070278
What this trial is testing

Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

Who this might be right for
Breast Cancer
Cambridge University Hospitals NHS Foundation Trust 800
Not applicableActive Not RecruitingNCT04854304
What this trial is testing

Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts

Who this might be right for
Breast Diseases
Abramson Cancer Center at Penn Medicine 500
Not applicableStudy completedNCT02695121
What this trial is testing

Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment

Who this might be right for
Breast CancerBladder Cancer
AstraZeneca 2,133,575
Not applicableUnknownNCT00509509
What this trial is testing

High Risk Breast Cancer Screening Program

Who this might be right for
Breast Cancer
Organisation for Oncology and Translational Research
Not applicableStudy completedNCT07229859
What this trial is testing

Robotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: a Safe and Effective Cosmetic Procedure in the Context of Prevalent Thyroid Ultrasound Screening

Who this might be right for
Differentiated Thyroid Cancer (DTC)Robotic Assistance
Ruijin Hospital 332
Testing effectiveness (Phase 2)Study completedNCT00562718
What this trial is testing

Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center 50
Not applicableStudy completedNCT06055803
What this trial is testing

Heart Health After Cancer Treatment (HEART-ACT)

Who this might be right for
Breast Cancer
University of California, San Francisco 50
Not applicableActive Not RecruitingNCT01953159
What this trial is testing

Assessment of Paclitaxel-Induced Neuropathy

Who this might be right for
CancerBreast CancerOvarian Cancer
University of Chicago 43
Large-scale testing (Phase 3)Study completedNCT02926196
What this trial is testing

Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody Avelumab

Who this might be right for
Triple Negative Breast Neoplasms
Istituto Oncologico Veneto IRCCS 474
Not applicableStudy completedNCT03069742
What this trial is testing

Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting

Who this might be right for
Breast Neoplasm
Columbia University 300
Not applicableLooking for participantsNCT07120087
What this trial is testing

Evaluation of an Online Intervention to Educate Women at High Risk of Breast Cancer on How to Help Reduce Their Risk.

Who this might be right for
Breast Cancer
UNICANCER 1,508
Testing effectiveness (Phase 2)Ended earlyNCT04578106
What this trial is testing

Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy

Who this might be right for
HER2-positive Breast CancerStage I Breast Cancer
Fundacio Clinic Barcelona 5
Not applicableStudy completedNCT03401034
What this trial is testing

Influence of Lifestyle, Inflammatory Biomarkers, and Genetic Factors on Long-term Breast Cancer Prognosis

Who this might be right for
Breast CancerBreast Cancer MortalityBreast Cancer Survival+7 more
German Cancer Research Center 3,813
Testing effectiveness (Phase 2)Study completedNCT00524277
What this trial is testing

Vaccine Therapy in Treating Patients With Breast Cancer

Who this might be right for
Breast Cancer
San Antonio Military Medical Center 456
Not applicableStudy completedNCT01817231
What this trial is testing

Epidemiological Analysis of Vitamin D and Breast Cancer Risk in Saudi Arabian Women

Who this might be right for
Breast CancerVitamin D Deficiency
University of Arizona 240
Next Page